Evidence map›Paper›PMID 31455651›Full record

ArticlemBio2019

Interferon-Induced Protein 44 Interacts with Cellular FK506-Binding Protein 5, Negatively Regulates Host Antiviral Responses, and Supports Virus Replication.

Marta L DeDiego, Aitor Nogales, Luis Martinez-Sobrido, David J Topham

Open access · goldAbstract read
In one paragraph

Article in mBio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Seasonal PMParticle and fibre toxicology · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Key genes and immune infiltration patterns and the clinical implications in psoriasis patients.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Marta L DeDiegoDavid H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, New York, USA Marta.lopez@cnb.csic.es David_Topham@URMC.rochester.edu.
Aitor NogalesDepartment of Microbiology and Immunology, University of Rochester, Rochester, New York, USA.
Luis Martinez-SobridoDepartment of Microbiology and Immunology, University of Rochester, Rochester, New York, USA.
David J TophamDavid H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, New York, USA Marta.lopez@cnb.csic.es David_Topham@URMC.rochester.edu.ORCID 0000-0002-9435-8673
University of Rochester · USCentro Nacional de Biotecnología · ES

Funding

NIAID NIH HHS HHSN272201400005C
6 · The paper itself

Abstract

Using multiple viral systems, and performing silencing approaches, overexpression approaches, and experiments in knockout cells, we report, for the first time, that interferon (IFN)-induced protein 44 (IFI44) positively affects virus production and negatively modulates innate immune responses induced after viral infections. Moreover, IFI44 is able to rescue poly(I·C)- and IFN-mediated inhibition of virus growth. Furthermore, we report a novel interaction of IFI44 with the cellular factor FK506-binding protein 5 (FKBP5), which binds to cellular kinases such as the inhibitor of nuclear factor kappa B (IκB) kinases (IKKα, IKKβ, and IKKε). Importantly, in the presence of FKBP5, IFI44 decreases the ability of IKKβ to phosphorylate IκBα and the ability of IKKε to phosphorylate interferon regulatory factor 3 (IRF-3), providing a novel mechanism for the function of IFI44 in negatively modulating IFN responses. Remarkably, these new IFI44 functions may have implications for diseases associated with excessive immune signaling and for controlling virus infections mediated by IFN responses.

Indexed as

Host-Pathogen InteractionsImmunity, InnateAntigensCytokinesCytoskeletal ProteinsHumansInterferonsPhosphorylationRNA VirusesRNA Virus InfectionsSignal TransductionTacrolimus Binding Protein 5Tacrolimus Binding ProteinsVirus ReplicationAntigensCytokinesCytoskeletal ProteinsIFI44 protein, humanInterferonsTacrolimus Binding Protein 5Tacrolimus Binding Proteinsantiviral responsesFKBP5IFI44IFN responsesinnate immunitysignaling transductionvirus-host interactions

Identifiers

PMID31455651
PMCPMC6712396
OpenAlexW2970860829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.